SYDNEY (Reuters) - Australia's competition regulator said on Thursday it was taking legal action against the local division of Pfizer Inc over the way it marketed its cholesterol-lowering drug Lipitor to pharmacies.
The Australian Competition and...
Company: PFIZER INC
News Subject: (Cholesterol & Hyperlipidemia (1CH66); Major Corporations (1MA93); Health & Family (1HE30); Obesity & Weight Control (1OB69); Health & Wellness (1HE60))
Industry: (Pharmaceuticals (1PH33); Pharmaceuticals Cost-Benefits (1PH30); Pharmaceuticals & Biotechnology (1PH13))
Region: (Americas (1AM92); Australasia (1AU56); Australia (1AU55); Oceania (1OC40); U.S. Mid-Atlantic Region (1MI18); North America (1NO39); USA (1US73); New York (1NE72))
Language: EN
Other Indexing: (Brendan McDermid Small; Brendan McDermid Slider)
Keywords: antitrust; health (MCC:OEC); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OEC)